glp 1 competitive landscape Obesity in the spotlight GLP-1 Patent Landscape: Shifting Dimensions

Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, not involved in this research, explained what this means for people taking GLP-agonists

Before Branded 10,85016,400 per month (Novo Nordisk Wegovy) Source: Business Today After Indian Generics 1,2904,500 per month (50+ brands) Source: Bloomberg Prices are indicative as of March 2026

Injection technique is identical for both medications: subcutaneous injection into the abdomen, thigh, or upper arm

This typically resolves quickly

An oral GLP1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice

These days, the initialism is much more recognizable